Skip to main content
Erschienen in: Cancer Causes & Control 5/2009

01.07.2009 | Original Paper

Case–control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma

verfasst von: Yukika Kakuta, Naoki Nakaya, Satoru Nagase, Megumi Fujita, Toshimitsu Koizumi, Chikako Okamura, Hitoshi Niikura, Kaori Ohmori, Shinichi Kuriyama, Toru Tase, Kiyoshi Ito, Yuko Minami, Nobuo Yaegashi, Ichiro Tsuji

Erschienen in: Cancer Causes & Control | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the association between green tea consumption and the risk of endometrial cancer restricted to endometrial endometrioid adenocarcinoma (EEA) using a case–control design in Japan.

Methods

The cases were 152 patients with histopathologically diagnosed EEA, and the controls were 285 healthy women who were matched for age and area of residence with individual cases. The subjects completed a questionnaire regarding health-related lifestyle and reproductive history, and a food frequency questionnaire. Odds ratios (ORs) of EEA for frequency of green tea consumption were calculated by conditional logistic regression analysis.

Results

We observed a significant inverse association between green tea consumption and the risk of EEA with a dose–response relationship. The multivariate-adjusted OR of EEA was 0.77 (95% CI: 0.37–1.58) for those in the second quartile of green tea consumption (5–6 cups/week–1 cup/day), 0.61 (0.30–1.23) in the third quartile (2–3 cups/day), and 0.33 (0.15–0.75) in the highest quartile (≥4 cups/day), as referenced with those in the lowest quartile (≤4 cups/week; p for trend = 0.007). This inverse association was consistently observed regardless of the presence or absence of factors such as obesity and menopause.

Conclusion

Green tea consumption may be associated with a lower risk of EEA.
Literatur
5.
Zurück zum Zitat Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S–3284SPubMed Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S–3284SPubMed
8.
Zurück zum Zitat Inoue M, Tajima K, Hirose K et al (1998) Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control 9:209–216. doi:10.1023/A:1008890529261 PubMedCrossRef Inoue M, Tajima K, Hirose K et al (1998) Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control 9:209–216. doi:10.​1023/​A:​1008890529261 PubMedCrossRef
12.
Zurück zum Zitat Xu WH, Dai Q, Xiang YB et al (2007) Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol 166:1420–1430. doi:10.1093/aje/kwm242 PubMedCrossRef Xu WH, Dai Q, Xiang YB et al (2007) Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol 166:1420–1430. doi:10.​1093/​aje/​kwm242 PubMedCrossRef
14.
Zurück zum Zitat Shimazu T, Inoue M, Sasazuki S et al (2008) Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 18 Aug 2008 (online in advance of print) Shimazu T, Inoue M, Sasazuki S et al (2008) Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 18 Aug 2008 (online in advance of print)
19.
Zurück zum Zitat SAS Institute Inc (2004) SAS/STAT user’s guide, release 9.1 edition. SAS Institute Inc, Cary SAS Institute Inc (2004) SAS/STAT user’s guide, release 9.1 edition. SAS Institute Inc, Cary
21.
Zurück zum Zitat Deligdisch L, Holinka CF (1987) Endometrial carcinoma: two diseases? Cancer Detect Prev 10:237–246PubMed Deligdisch L, Holinka CF (1987) Endometrial carcinoma: two diseases? Cancer Detect Prev 10:237–246PubMed
22.
Zurück zum Zitat Christopher P, Crum KRL (2006) Diagnostic gynecologic and obstetric pathology. Elsevier Saunders, Philadelphia, pp 546–548 Christopher P, Crum KRL (2006) Diagnostic gynecologic and obstetric pathology. Elsevier Saunders, Philadelphia, pp 546–548
23.
Zurück zum Zitat Ohta H, Makita K (2000) Horumon hojyu ryouhou. Sanhujinka no jissai (Japanese) 49:1669–1676 Ohta H, Makita K (2000) Horumon hojyu ryouhou. Sanhujinka no jissai (Japanese) 49:1669–1676
25.
Zurück zum Zitat Koizumi Y, Tsubono Y, Nakaya N et al (2003) No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiol Biomarkers Prev 12:472–473PubMed Koizumi Y, Tsubono Y, Nakaya N et al (2003) No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiol Biomarkers Prev 12:472–473PubMed
26.
Zurück zum Zitat Suzuki Y, Tsubono Y, Nakaya N, Koizumi Y, Shibuya D, Tsuji I (2005) Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan. J Epidemiol 15:118–124. doi:10.2188/jea.15.118 PubMedCrossRef Suzuki Y, Tsubono Y, Nakaya N, Koizumi Y, Shibuya D, Tsuji I (2005) Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan. J Epidemiol 15:118–124. doi:10.​2188/​jea.​15.​118 PubMedCrossRef
29.
30.
Zurück zum Zitat Luo J, Inoue M, Iwasaki M et al (2007) Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 16(6):542–548PubMedCrossRef Luo J, Inoue M, Iwasaki M et al (2007) Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 16(6):542–548PubMedCrossRef
31.
Zurück zum Zitat Zhang M, Binns CW, Lee AH (2002) Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev 11(8):713–718PubMed Zhang M, Binns CW, Lee AH (2002) Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev 11(8):713–718PubMed
Metadaten
Titel
Case–control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma
verfasst von
Yukika Kakuta
Naoki Nakaya
Satoru Nagase
Megumi Fujita
Toshimitsu Koizumi
Chikako Okamura
Hitoshi Niikura
Kaori Ohmori
Shinichi Kuriyama
Toru Tase
Kiyoshi Ito
Yuko Minami
Nobuo Yaegashi
Ichiro Tsuji
Publikationsdatum
01.07.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 5/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9272-0

Weitere Artikel der Ausgabe 5/2009

Cancer Causes & Control 5/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.